Experienced in Gastrostomy

Dr. Daniel Dilling

Intensive Care Medicine
Loyola University Medical Center
2160 S 1st Ave, 
Maywood, IL 
Experienced in Gastrostomy
Loyola University Medical Center
2160 S 1st Ave, 
Maywood, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Daniel Dilling is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Dilling is rated as an Experienced provider by MediFind in Gastrostomy. His top areas of expertise are Lymphangioleiomyomatosis, Acute Interstitial Pneumonia, Idiopathic Pulmonary Fibrosis, Lung Transplant, and Gastrostomy.

His clinical research consists of co-authoring 50 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Intensive Care Medicine
Licenses
Internal Medicine in IL
Hospital Affiliations
Loyola University Medical Center
Elmhurst Memorial Hospital
Saint Francis Medical Center
Northwestern Medicine Central Dupage Hospital
Advocate Good Shepherd Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Zing Health
  • MEDICARE MAPD
  • MEDICARE SNP
View 15 Less Insurance Carriers -

Locations

Loyola University Medical Center
2160 S 1st Ave, Maywood, IL 60153
Other Locations
Office
1S260 Summit Ave, Oakbrook Terrace, IL 60181

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-1)
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2025
Intervention Type: Device, Drug
Study Drug: Treprostinil
Study Phase: Phase 3
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Phase 1b Double-Blind, Placebo-Controlled, Ascending Dose Trial: ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Suspended
Publish Date: May 30, 2025
Intervention Type: Drug
Study Drug: ORIN1001
Study Phase: Phase 1
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Biological Activity, and PK of ND-L02-s0201 in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Completed
Publish Date: December 11, 2023
Intervention Type: Drug, Other
Study Drug: ND-L02-s0201
Study Phase: Phase 2
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
A Randomized, Double-Blind, Placebo-Controlled Dose Escalation and Verification Clinical Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide (iNO) in Subjects at Risk of Pulmonary Hypertension Associated With Pulmonary Fibrosis on Long Term Oxygen Therapy (Part 1 and Part 2) - REBUILD
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Combination product
Study Drug: INOpulse
Study Phase: Phase 3
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis
Enrollment Status: Completed
Publish Date: September 04, 2020
Intervention Type: Drug
Study Phase: Phase 2
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Enrollment Status: Terminated
Publish Date: July 30, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 5 Less Clinical Trials

50 Total Publications

Are donor-specific antibodies really all that "baseline lung allograft dysfunction"?
Are donor-specific antibodies really all that "baseline lung allograft dysfunction"?
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: June 25, 2025
Similar Doctors
Distinguished in Gastrostomy
Dr. Bharat S. Bhandari
Intensive Care Medicine
Distinguished in Gastrostomy
Dr. Bharat S. Bhandari
Intensive Care Medicine

Aurora Lakeland Medical Center

W3985 County Road NN, 
Elkhorn, WI 
 (61.8 miles away)
262-741-2000
Languages Spoken:
English
See accepted insurances

Bharat Bhandari is an Intensive Care Medicine provider in Elkhorn, Wisconsin. Dr. Bhandari is rated as a Distinguished provider by MediFind in Gastrostomy. His top areas of expertise are Gastrostomy and Endoscopy.

Advanced in Gastrostomy
Dr. Hieu Ton
Intensive Care Medicine
Advanced in Gastrostomy
Dr. Hieu Ton
Intensive Care Medicine

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (7.2 miles away)
708-216-9000
Languages Spoken:
English
See accepted insurances

Hieu Ton is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Ton is rated as an Advanced provider by MediFind in Gastrostomy. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Subdural Hematoma, Delirium, Gastrostomy, and Hernia Surgery.

Advanced in Gastrostomy
Dr. Richard Gonzalez
Intensive Care Medicine
Advanced in Gastrostomy
Dr. Richard Gonzalez
Intensive Care Medicine

Loyola University Medical Center

2160 S 1st Ave, 
Maywood, IL 
 (7.2 miles away)
708-216-9000
Languages Spoken:
English
See accepted insurances

Richard Gonzalez is an Intensive Care Medicine provider in Maywood, Illinois. Dr. Gonzalez is rated as an Advanced provider by MediFind in Gastrostomy. His top areas of expertise are Delirium, Subdural Hematoma, Chronic Subdural Hematoma, Gastrostomy, and Gallbladder Removal.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Dilling's expertise for a condition
ConditionClose
View All 27 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile